Skip to main content

Wednesday, November 16, 2005

Ingen Technologies, Inc. EXPANDS SECURE BALANCE DISTRIBUTION
-IGTN Opens Market In New England States-

 

Calimesa, CA- November 16, 2005 at 7:15 AM (EST) - Ingen Technologies, Inc. (OTC: IGTN), a medical device manufacturer of OxyAlert™, OxyView™, and Secure Balance™, announces the strategic exclusive distribution agreement with Siegel Performance Systems, Inc.
 
Siegel Performance Systems has been a distributor of fitness and rehabilitation products for over 25 years, and has provided products for professional sports, hospitals and clinics throughout the New England area. Siegel Performance Systems is also known to provide the best service in the industry with well-trained customer service representatives with high quality; factory trained certified technicians throughout the country to provide the most professional service in the industry.


 SIEGEL PERFORMANCE SYSTEMS
12 Christa Court
Huntington, NY 11743
 
Mark Siegel
President
Phone: 631-367-9044
Fax: 631-367-2648
Email: [email protected]

Scott Sand, CEO & Chairman stated; “We now have a strong distribution rep group in the New England area that has an established client base and strong reputation. We will support Siegel Performance Systems with the Secure Balance™ brand of products and services, as well as an affective advertising campaign.”

Siegel Performance Systems has 45 reps that will distribute Secure Balance™ products and services. Secure Balance™ offers a complete approach to the evaluation of balance and fall prevention, offering both the diagnostic and the rehabilitative tools to help patients regain their balance.
 

About Ingen Technologies, Inc.

 Ingen Technologies, Inc. is a public company trading under NASDAQ OTC:IGTN, which has been in business since 1999.  IGTN is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products.

The Company’s flagship product is OxyAlert™, a second-generation design of the Company’s BAFI™ product line.  Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001.  Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment.  OxyAlert™ technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.

The newest product, OxyView™, has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow to hospitalized patients.  This product enhances the safety, assurance and accuracy of hospitalized patients being administered oxygen from any source.  OxyView™ is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck.  It informs the nursing staff of oxygen flow rate near the patient.  It could quickly inform the hospital staff of any leak or inaccuracy between the delivery source and the patient.

The Secure Balance™ product is a private-label product that includes a vestibular function testing system and balance therapy system.  The vestibular function testing system is manufactured by Interacoustics LTD. in Denmark and is referred to as the VNG.  The balance therapy system is manufactured by SportKAT®, Inc. in San Diego, California.  The Secure Balance™ program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.

The Pure Produce™ product is a continuing research & development program currently under design.  This program uses hydroponics technology to grow various plants without the use of soil, fertilizer and water consumption.  The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.

“Our team of professionals has developed our medical products for the ever-increasing elderly population.  Our products are superior to any of our competition and they allow for effective medical product availability to seniors, and at the same time the increasing senior population allows for a steady growth in sales and profits,” said Scott Sand, CEO & Chairman of Ingen Technologies. 
 
For more information, visit  www.ingen-tech.com

Investor Relations Contact:  Scott R. Sand, C.E.O & Chairman
Ingen Technologies, Inc. - Administrative Office
35193 Avenue "A", Suite-C
Yucaipa, California 92399
Phone: (800) 259-9622 or (909) 790-7180
Fax: (800) 777-1186 or (909) 795-6340
Email: [email protected]
A Member of the Better Business Bureau
A Member of the Chamber of Commerce
     A Licensed Business in the City of Yucaipa
 
Safe Harbor for Forward-Looking Statements:  This news release includes forward-looking statements that are made pursuant to “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995.  While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion.  Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described.  The company’s operations and business prospects are always subject to risk and uncertainties.  Important factors that may cause actual results to differ will be set forth in the company’s periodic filings (the first of which, since reporting ceased in 1998, will be filed shortly) with the U.S. Securities and Exchange Commission.

Download this article in PDF format: mso14C8.pdf